MedTrace Logo

The Predictive Value of Alarm Symptoms in Patients With Dyspepsia Based on Roman IV

NCT03479528 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2019-01-14

No results posted yet for this study

Summary

Functional dyspepsia is one of the most common gastrointestinal disorders (FGIDs) encountered in clinical practice.Clinical diagnosis is notoriously unreliable in diagnosing the underlying cause of dyspepsia,but a number of alarm features have been suggested as indicating patients at higher risk for serious disease. The predictive value of alarm symptoms still require more researches. Rome IV introduced more precisely define the minimal thresholds for frequency and severity of each individual symptom, primarily for scientific purposes,but data still need to be collected to define thresholds based on the frequency and/or severity of symptoms that impair quality of life.A cross-sectional study was conducted to assess the predictive value of alarm symptoms in patients with dyspepsia based on Roman IV.Through endoscopy results to determine whether dyspepsia is organic or functional, benign or malignant, through contacts with the basic data, to determine the alarm symptoms

Conditions

  • Dyspepsia

Sponsors & Collaborators

  • Xi'an No.3 Hospital

    collaborator OTHER_GOV

  • Xijing Hospital

    collaborator OTHER

  • Tang-Du Hospital

    collaborator OTHER

  • Second Affiliated Hospital of Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Jinhai Wang, MD · The Second Affiliated Hospital of Xi'an Jiaotong University,Xi'an, Shaanxi, China

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03479528 on ClinicalTrials.gov